Literature DB >> 14527089

Disposition of quercetin and kaempferol in human following an oral administration of Ginkgo biloba extract tablets.

F M Wang1, T W Yao, S Zeng.   

Abstract

Ten adult volunteers with an average age 28 years were given a single oral dose of six tablets of Ginkgo biloba extract. Quercetin and kaempferol in different period of human urine were determined by using RP-HPLC. The results showed the elimination rate constant k and the absorption rate constant ka of quercetin were slightly more than that of kaempferol; and the absorption half-life (t(1/2a)), the elimination half-life (t(1/2)) and t(max) of quercetin were less than that of kaempferol, the differences were, however, not statistically significant. The mean values of ka were 0.61 h(-1) and 0.55 h(-1), t(1/2a) 1.51 h and 1.56 h, k 0.37 h(-1) and 0.30 h(-1), t(1/2) 2.17 h and 2.76 h, T(max) 2.30 h and 2.68 h for quercetin and kaempferol, respectively, which mean absorption and elimination of quercetin and kaempferol are 0.17% and 0.22%, respectively. Quercetin and kaempferol are excreted in the human urine mainly as glucuronides.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14527089     DOI: 10.1007/BF03190482

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  4 in total

1.  Human absorption and excretion of flavonoids after broccoli consumption.

Authors:  S E Nielsen; M Kall; U Justesen; A Schou; L O Dragsted
Journal:  Cancer Lett       Date:  1997-03-19       Impact factor: 8.679

2.  Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man.

Authors:  P C Hollman; J M van Trijp; M N Buysman; M S van der Gaag; M J Mengelers; J H de Vries; M B Katan
Journal:  FEBS Lett       Date:  1997-11-24       Impact factor: 4.124

3.  Comparative pharmacokinetics and bioavailability of flavonoid glycosides of Ginkgo biloba after a single oral administration of three formulations to healthy volunteers.

Authors:  J Wójcicki; B Gawrońska-Szklarz; W Bieganowski; M Patalan; H K Smulski; L Samochowiec; J Zakrzewski
Journal:  Mater Med Pol       Date:  1995 Oct-Dec

4.  Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers.

Authors:  P C Hollman; J H de Vries; S D van Leeuwen; M J Mengelers; M B Katan
Journal:  Am J Clin Nutr       Date:  1995-12       Impact factor: 7.045

  4 in total
  5 in total

Review 1.  First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics.

Authors:  Baojian Wu; Kaustubh Kulkarni; Sumit Basu; Shuxing Zhang; Ming Hu
Journal:  J Pharm Sci       Date:  2011-04-11       Impact factor: 3.534

Review 2.  Ginkgo biloba extracts: a review of the pharmacokinetics of the active ingredients.

Authors:  Christian Ude; Manfred Schubert-Zsilavecz; Mario Wurglics
Journal:  Clin Pharmacokinet       Date:  2013-09       Impact factor: 6.447

Review 3.  Biomarkers of legume intake in human intervention and observational studies: a systematic review.

Authors:  Pedapati S C Sri Harsha; Roshaida Abdul Wahab; Mar Garcia-Aloy; Francisco Madrid-Gambin; Sheila Estruel-Amades; Bernhard Watzl; Cristina Andrés-Lacueva; Lorraine Brennan
Journal:  Genes Nutr       Date:  2018-09-10       Impact factor: 5.523

Review 4.  Pharmacokinetic, Metabolism, and Metabolomic Strategies Provide Deep Insight Into the Underlying Mechanism of Ginkgo biloba Flavonoids in the Treatment of Cardiovascular Disease.

Authors:  Yi Tao; Fei Zhu; Meiling Pan; Qing Liu; Ping Wang
Journal:  Front Nutr       Date:  2022-03-23

Review 5.  Ellagic Acid, Kaempferol, and Quercetin from Acacia nilotica: Promising Combined Drug With Multiple Mechanisms of Action.

Authors:  Mosab Yahya Al-Nour; Musab Mohamed Ibrahim; Tilal Elsaman
Journal:  Curr Pharmacol Rep       Date:  2019-05-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.